Case report: gestational trophoblastic neoplasia with hypovolemic shock
DOI:
https://doi.org/10.35509/01239015.1023Keywords:
trophoblastic neoplasms, choriocarcinoma, gestational trophoblastic disease, pregnancy, ectopic, hydatidiform mole, invasive, hypovolemic shockAbstract
Gestational trophoblastic neoplasia includes invasive moles (locally invasive, rarely metastatic lesions, characterized microscopically by trophoblastic invasion of the myometrium with identifiable villous structures), choriocarcinoma (malignant tumor of the trophoblastic epithelium), and placental site trophoblastic tumors (very rare tumors that originate at the site of placental implantation and resemble an exaggerated form of syncytial endometritis). Of these types of neoplasms, invasive hydatidiform mole is a rare form of gestational trophoblastic disease, whereas choriocarcinoma is an aggressive and rare placental tumor. In this report, we present the case of a 34-year-old female patient with a history of fetal death, whose diagnosis was a documented choriocarcinoma of an ectopic pregnancy with massive hemoperitoneum and hypovolemic shock, with metastases in the lung and abdomen. After diagnosis, treatment with EMA-CO chemotherapy was started.
Author Biographies
Julián Yáñez-Hartmann, Ginecología oncológica, Clínica Medical Duarte, Cúcuta, Colombia.
1. Ginecología oncológica, Clínica Medical Duarte, Cúcuta, Colombia.
Emily Gabriela Becerra-Leal, Estudiante de pregrado en Medicina, Departamento de Medicina, Universidad de Pamplona, Cúcuta, Colombia.
2. Estudiante de pregrado en Medicina, Departamento de Medicina, Universidad de Pamplona, Cúcuta, Colombia.
Adriana del Pilar Becerra-Guerrero, Estudiante de pregrado en Medicina, Departamento de Medicina, Universidad de Pamplona, Cúcuta, Colombia.
2. Estudiante de pregrado en Medicina, Departamento de Medicina, Universidad de Pamplona, Cúcuta, Colombia.
Edgar Andrés Ortiz-Jaimes, Estudiante de pregrado en Medicina, Departamento de Medicina, Universidad de Pamplona, Cúcuta, Colombia.
2. Estudiante de pregrado en Medicina, Departamento de Medicina, Universidad de Pamplona, Cúcuta, Colombia.
Luz Patricia Cruz-Mojica, Hospital Universitario Erasmo Meoz, Cúcuta, Colombia.
3. Hospital Universitario Erasmo Meoz, Cúcuta, Colombia.
References
Bruce S, Sorosky J. Gestational trophoblastic disease [Internet]. En: StatPearls. Treasure Island, Florida, Estados Unidos: StatPearls Publishing; 2023. [actualizado 2023 nov. 12; citado 2023 nov. 17]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK470267/
AlJulaih G, Muzio M. Gestational trophoblastic neoplasia [Internet]. En: StatPearls. Treasure Island, Florida, Estados Unidos: StatPearls Publishing; 2023. [actualizado 2023 nov. 12; citado 2023 nov. 17]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK562225/
Lozano-Vidal M, Sánchez-Reyman J, Machuca-Aguado J, Sánchez-Bernal M, Martínez-Roche M. Diagnóstico y tratamiento quirúrgico de una paciente con una neoplasia trofoblástica gestacional. Ginecol Obstet Mex. 2023;91(3):210-17. https://doi.org/10.24245/gom.v91i3.7748
Berkowitz R, Horowitz N, Elias K. Hydatidiform mole: epidemiology, clinical features, and diagnosis [Internet]. En: Goff B, editor. UpToDate. Waltham, Massachusetts, Estados Unidos. [actualizado 2023 my. 10; citado 2023 nov. 20]. Disponible en: https://www.uptodate.com/contents/hydatidiform-mole-epidemiology-clinical-features-and-diagnosis?search=Hydatidiform%20mole:%20Epidemiology,%20clinical%20features,%20and%20diagnosis.&source=search_result&selectedTitle=1~48&usage_type=default&display_rank=1
Biscaro A, Braga A, Berkowitz R. Diagnosis, classification and treatment of gestational trophoblastic neoplasia. Rev Bras Ginecol Obstet. 2015;37(1):42-51. https://doi.org/10.1590/SO100-720320140005198
Aparicio-Rubio C, Hernández-Lorente E, Escoin-Pérez C. Coriocarcinoma: a propósito de un caso. Farm Hosp. 2017;41(6):692-93. https://doi.org/10.7399/fh.10831
van Cromvoirt S, Thomas C, Quinn M, McNally O, Bekkers R. Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve. Gynecol Oncol. 2014; 133(3):542-5. https://doi.org/10.1016/j.ygyno.2014.03.018
Villegas-Mejía C, Chacón-Cardona J, Villegas-Jaramillo M. Enfermedad trofoblástica gestacional en un centro oncológico de Caldas - Colombia durante el periodo 2001 - 2014. Médicas UIS. 2017;30(3):39-49. https://doi.org/10.18273/revmed.v30n3-2017004
Zuñiga J. Enfermedad trofoblástica. Rev Colomb Obstet Ginecol. 1985;36(2):113-22. http://doi.org/10.18597/rcog.1734
Malovrh E, Lukinovič N, Bujas T, Sobočan M, Knez J. Ultra-high-risk gestational choriocarcinoma of the ovary associated with ectopic pregnancy. Curr Oncol. 2023;30(2):2217-26. https://doi.org/10.3390%2Fcurroncol30020171
Bishop B, Edemekong P. Choriocarcinoma [Internet]. En: StatPearls. Treasure Island, Florida, Estados Unidos: StatPearls Publishing; 2023. [actualizado 2023 febr. 4; citado 2023 nov. 21]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK535434/
Brenes Valverde I, Mora Morales A, Prendas Navarro K. Análisis clínico y patológico del coriocarcinoma gestacional. Rev Méd Sinerg. 2022;7(3):e776. https://doi.org/10.31434/rms.v7i3.776
Savage P, Kelpanides I, Tuthill M, Short D, Seckl M. Brain metastases in gestational trophoblast neoplasia: an update on incidence, management and outcome. Gynecol Oncol. 2015;137(1):73-6. https://doi.org/10.1016/j.ygyno.2015.01.530
Ding W, Zhang N, Rao Y, Xu X, Nie T, Qu P. A successfully treated multiple metastatic choriocarcinoma coexistent with live fetus: a case report and literature review. Front Oncol. 2022;11:777707. https://doi.org/10.3389/fonc.2021.777707
Agustín A, Savirón R, Lerma D, Herrero A, Campillos J. Coriocarcinoma postgestacional. Rev Chil Obstet Ginecol. 2015;80(5):405-11. http://doi.org/10.4067/S0717-75262015000500009
Sociedad Española de Ginecología y Obstetricia. Enfermedad trofoblástica gestacional. Prog Obstet Ginecol. 2020;63(3):165-84. Disponible en: https://sego.es/documentos/progresos/v63-2020/n3/05-GAP-enfermedad-trofoblastica-gestacional.pdf
Tidy J, Seckl M, Hancock B, a nombre del Royal College of Obstetricians and Gynaecologists. Management of gestational trophoblastic disease. BJOG. 2021;128(3):e1-27. https://doi.org/10.1111/1471-0528.16266
Jaz K, Miedziarek C, Piasek E, Florek A, Nowak-Markwitz E, Zaborowski M. Choriocarcinoma complicated with intra-abdominal and intrapleural hemorrhage in pregnancy - case report. Front Oncol. 2023;13:1198553. https://doi.org/10.3389/fonc.2023.1198553
Li J, Yang J, Liu P, Ren T, Zhao J, Feng F, et al. Clinical characteristics and prognosis of 272 postterm choriocarcinoma patients at Peking Union Medical College Hospital: a retrospective cohort study. BMC Cancer. 2016;16:347. https://doi.org/10.1186%2Fs12885-016-2383-1
Berkowitz R, Horowitz N, Elias K. Gestational trophoblastic neoplasia: epidemiology, clinical features, diagnosis, staging, and risk stratification [Internet]. En: Goff B, Dizon DS, editores. UpToDate. Waltham, Massachusetts, Estados Unidos. [actualizado 2022 nov. 14; citado 2023 nov. 11]. Disponible en: https://www.uptodate.com/contents/gestational-trophoblastic-neoplasia-epidemiology-clinical-features-diagnosis-staging-and-risk-stratification?search=estational%20trophoblastic%20neoplasia:%20Epidemiology,%20clinical%20features,%20diagnosis,%20staging,%20and%20risk%20stratification.%20&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Ngan H, Seckl M, Berkowitz R, Xiang Y, Golfier F, Sekharan P, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynecol Obstet. 2021;155(supl. 1):86-93. https://doi.org/10.1002/ijgo.13877
Moreno-Gomez B, Castillo-Aznar J, Tejedor-Vargas P, Delgado-Domingo J, Millaruelo-Rami A, Pérez-Morente M, et al. Coriocarcinoma de placenta metastásico en embarazo de 34 semanas: revisión y manejo. Cir Cir. 2021;89(4):534-7. https://doi.org/10.24875/ciru.19001402
Alazzam M, Tidy J, Osborne R, Coleman R, Hancock B, Lawrie T. Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev. 2016;2016(1):CD008891. https://doi.org/10.1002/14651858.cd008891.pub3
Ji M, Jiang S, Zhao J, Wan X, Feng F, Ren T, et al. Efficacies of FAEV and EMA/CO regimens as primary treatment for gestational trophoblastic neoplasia. Br J Cancer. 2022;127(3):524-30. https://doi.org/10.1038/s41416-022-01809-3
Braga A, Elias K, Horowitz N, Berkowitz R. Treatment of high-risk gestational trophoblastic neoplasia and chemoresistance/relapsed disease. Best Pract Res Clin Obstet Gynaecol. 2021;74:81-96. https://doi.org/10.1016/j.bpobgyn.2021.01.005
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Colombiana de Cancerología
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Todos los derechos reservados.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
